Catenae Innovation’s Guy Meyer () and BHA Medical’s Gavyn Hough talks to Proactive London after the announcement of their joint venture to deliver an integrated COVID-19 test.
Meyer believes this partnership is strategically aligned and both counterparts complement each other’s offering, with Catenae providing the technology part of this team.
Hough explains their global role and in supplying 350,000 kits to date to FTSE 100 companies. He says: ‘We have the science, they have the technology and as a solution that is a match made in heaven’.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…
In exchange for publishing services rendered by the Company on behalf of Catenae Innovation PLC named herein, including the promotion by the Company of Catenae Innovation PLC in any Content on the Site, the Company…
FOR OUR FULL DISCLAIMER CLICK HERE